Additionally, our study emphasizes the possibility of developing targeted drugs that specifically activate TRIM21, presenting a promising therapeutic approach for the treatment of colorectal cancer and opening up new avenues for clinical intervention. Here, TRIM21 is linked to colorectal cancer.